Cancer meds added to reimbursement list

Reduced prices will make treatments more affordable to those with disease

China has added a range of innovative cancer drugs to a list of medicines eligible for reimbursement from the national insurance system, medical and social security authorities said on Thursday.

In total, 70 new therapies have made it to the expanded list after monthslong price negotiations with authorities, offering an average price reduction of 60.7 percent, according to the National Healthcare Security Administration, who announced the adjustment with the Ministry of Human Affairs and Social Security.